[4S05a] Update of oligonucleotide therapy as a major trend of drug discovery for intractable neurological diseases

[4S05a-04] Precision medicine with antisense oligonucleotides for neurological disorders

*Tojo Nakayama^1,2, Timothy W Yu¹ (1. Harvard Medical School, Boston Children's Hospital, MA, USA, 2. Tokyo Medical and Dental University, Tokyo, Japan)

Keywords:PRECISION MEDICINE, ANTISENSE OLIGONUCLEOTIDE, DRUG DEVELOPMENT, NEUROLOGICAL RARE DISEASES